1. Summary Information

		Country	India
Company Name	AQUATIC REMEDIES PRIVATE LIMITED	Principal Name 1	Mr. Bharat Nyalchand Mehta
Status	Moderate	Principal Name 2	Mr. Hitendra Nyalchand Mehta
		Registration #	11-097828
Street Address	218/219, Kailash Plaza, Vallabh Baug Lane, Ghatkopar (East), Mumbai – 400 075, Maharashtra, India
Established Date	04.03.1996	SIC Code	--
Telephone#	91-22-67255555	Business Style 1	Trader
Fax #	91-22-67991766	Business Style 2	Exporter
Homepage	www.aquaticremedies.net	Product Name 1	Macrolides
# of employees	55 (Approximately)	Product Name 2	Ethambutol
Paid up capital	Rs. 96,700,000/-	Product Name 3	Pyrazinamide
Shareholders	Bodies corporate -28.85% Directors or relatives of Directors -53.78% Others -17.37%	Banking	Bank of Maharashtra
Public Limited Corp.	No	Business Period	16 Years
IPO	No	International Ins.	-
Public Enterprise	No	Rating	B (33)
Related Company
Relation	Country	Company Name	CEO
Enterprises over which Key Management Personnel and their relatives exercise significant influence or control :	India	Oceanic Techno Chem Private Limited	--
Note	-

2. Summary Financial Statement

Balance Sheet as of	31.03.2011		(Unit: Indian Rs.)
Assets		Liabilities
Current Assets	776,506,000	Current Liabilities	565,453,000
Inventories	95,672,000	Long-term Liabilities	139,797,000
Fixed Assets	6,638,000	Other Liabilities	29,580,000
Deferred Assets	0,000	Total Liabilities	734,830,000
Invest& other Assets	21,611,000	Retained Earnings	68,897,000
		Net Worth	165,597,000
Total Assets	900,427,000	Total Liab. & Equity	900,427,000
Total Assets (Previous Year)	810,927,000
P/L Statement as of	31.03.2011		(Unit: Indian Rs.)
Sales/ Total Income	NA	Net Profit	NA
Sales/ Total Income (Previous yr)	1,789,181,000	Net Profit(Prev.yr)	12,704,000

MIRA INFORM REPORT

Report Date :

21.08.2012

IDENTIFICATION DETAILS

Name :	AQUATIC REMEDIES PRIVATE LIMITED
Registered Office :	218/219, Kailash Plaza, Vallabh Baug Lane, Ghatkopar (East), Mumbai – 400075, Maharashtra
Country :	India
Financials (as on) :	31.03.2011
Date of Incorporation :	04.03.1996
Com. Reg. No.:	11-097828
Capital Investment / Paid-up Capital :	Rs.96.700 Millions
CIN No.: [Company Identification No.]	U24230MH1996PTC097828
TAN No.: [Tax Deduction & Collection Account No.]	MUMA11886A
PAN No.: [Permanent Account No.]	AABCA3876G
Legal Form :	Private Limited Liability Company
Line of Business :	Trader, Exporter and Importers of Pharmaceutical Raw Materials and Bulk Active Ingredients.
No. of Employees :	55 (Approximately)

RATING & COMMENTS

MIRA’s Rating :

B (33)

RATING		STATUS	PROPOSED CREDIT LINE
26-40	B	Capability to overcome financial difficulties seems comparatively below average.	Small

Maximum Credit Limit :	USD 660000
Status :	Moderate
Payment Behaviour :	Slow but correct
Litigation :	Clear
Comments :	Subject is an established company having moderate track. Even though the company has achieved a better sales turnover, there appears some dip in its profitability during 2011. However, trade relations are reported as fair. Business is active. Payments are reported to be slow but correct. The company can be considered for business dealings with some caution.

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

ECGC Country Risk Classification List – June 30, 2012

Country Name	Previous Rating (31.03.2012)	Current Rating (30.06.2012)
India	A1	A1

Risk Category	ECGC Classification
Insignificant	A1
Low	A2
Moderate	B1
High	B2
Very High	C1
Restricted	C2
Off-credit	D

RBI DEFAULTERS’ LIST STATUS

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

INFORMATION PARTED BY

Name :	Mr. Bharat Nyalchand Mehta
Designation :	Chairman cum Managing Director
Contact No.:	91-9821262142
Date :	20.08.2012

LOCATIONS

Registered Office :	218/219, Kailash Plaza, Vallabh Baug Lane, Ghatkopar (East), Mumbai – 400 075, Maharashtra, India
Tel. No.:	91-22-67255555 (5 Lines) / 55958111
Mobile No.:	91-9821262142 (Mr. Bharat N Mehta)
Fax No.:	91-22-67991766
E-Mail :	forum_1979@rediffmail.com afil@vsnl.net forum.fga@gmail.com kirti@aquaticremedies.net bharat@aquaticremedies.net aquaticremedies@msn.com
Website :	http://www.aquaticremedies.net
Area :	1000 Sq. Ft. Super build up
Location :	Owned
Corporate Office / Branch Office:	36, Amul Estate, Near Railway Crossing, Sarkhej, Ahmedabad – 382210, Gujarat, India
Area :	500 Sq. ft
Location :	Owned
Warehouse :	Bhiwandi Sobhagya Ware Housing Complex, Rahanal Village, Bhiwandi, Thane – 421302, Maharashtra India
Location :	Owned

DIRECTORS

As on 30.09.2011

Name :

Mr. Bharat Nyalchand Mehta

Designation :

Chairman cum Managing Director

Address :

255/11, Prity, R.N.N, Road, Gathkopar (East), Mumbai 400077, Maharashtra, India

Date of Birth/Age :

24.10.1960

Qualification :

B Pharm

Date of Appointment :

04.03.1996

DIN No :

00580554

Other Directorship

S.No.	CIN/LLPIN	Name of the Company/ LLP	Current designation of the Director/ Designated Partner	Date of appointment at current designation	Original date of appointment	Date of cessation	Company/ LLP Status	Defaulting status
1	U24230MH1996PTC097828	AQUATIC REMEDIES PRIVATE LIMITED	Director	04/03/1996	04/03/1996	-	Active	NO
2	U24210MH1996PTC097827	OCEANIC TECHNO CHEM PRIVATE LIMITED	Director	04/03/1996	04/03/1996	-	Active	NO
3	U24230MH1999PLC122956	AQUATIC FORMULATIONS (INDIA) LIMITED	Director	07/12/1999	07/12/1999	-	Active	NO
4	U85100MH2010PTC201945	OCEANIC MEDI-TREAT PRIVATE LIMITED	Director	12/4/2010	12/4/2010	-	Active	NO

Name :

Mr. Hitendra Nyalchand Mehta

Designation :

Director

Address :

255/11, Prity, R.N.N, Road, Gathkopar (East), Mumbai 400077, Maharashtra, India

Date of Birth/Age :

09.09.1969

Qualification :

BE

Date of Appointment :

04.03.1996

DIN No :

00580562

Other Directorship

S.No.	CIN/LLPIN	Name of the Company/ LLP	Current designation of the Director/ Designated Partner	Date of appointment at current designation	Original date of appointment	Date of cessation	Company/ LLP Status	Defaulting status
1	U24230MH1996PTC097828	AQUATIC REMEDIES PRIVATE LIMITED	Director	04/03/1996	04/03/1996	-	Active	NO
2	U24210MH1996PTC097827	OCEANIC TECHNO CHEM PRIVATE LIMITED	Director	04/03/1996	04/03/1996	-	Active	NO
3	U24230MH1999PLC122956	AQUATIC FORMULATIONS (INDIA) LIMITED	Managing director	01/4/2010	07/12/1999	-	Active	NO

Name :

Mr. Kirti Bhogilal Mehta

Designation :

Director

Address :

255/11, Prity, R.N.N, Road, Gathkopar (East), Mumbai 400077, Maharashtra, India

Date of Birth/Age :

31.12.1970

Qualification :

B.Com

Date of Appointment :

04.03.1996

DIN No :

00580572

Other Directorship

S.No.	CIN/LLPIN	Name of the Company/ LLP	Current designation of the Director/ Designated Partner	Date of appointment at current designation	Original date of appointment	Date of cessation	Company/ LLP Status	Defaulting status
1	U24210MH1996PTC097827	OCEANIC TECHNO CHEM PRIVATE LIMITED	Director	04/03/1996	04/03/1996	-	Active	NO
2	U24230MH1996PTC097828	AQUATIC REMEDIES PRIVATE LIMITED	Director	04/03/1996	04/03/1996	-	Active	NO
3	U24230MH1999PLC122956	AQUATIC FORMULATIONS (INDIA) LIMITED	Director	07/12/1999	07/12/1999	-	Active	NO

Name :

Mr. Darshan Bhogilal Mehta

Designation :

Director

Address :

255/11, Prity, R.N.N, Road, Gathkopar (East), Mumbai 400077, Maharashtra, India

Date of Birth/Age :

07.07.1977

Qualification :

B.Com

Date of Appointment :

04.03.1996

DIN No :

00580585

Other Directorship

S.No.	CIN/LLPIN	Name of the Company/ LLP	Current designation of the Director/ Designated Partner	Date of appointment at current designation	Original date of appointment	Date of cessation	Company/ LLP Status	Defaulting status
1	U24230MH1996PTC097828	AQUATIC REMEDIES PRIVATE LIMITED	Director	04/03/1996	04/03/1996	-	Active	NO
2	U24230MH1999PLC122956	AQUATIC FORMULATIONS (INDIA) LIMITED	Director	07/12/1999	07/12/1999	-	Active	NO
3	U24210MH1996PTC097827	OCEANIC TECHNO CHEM PRIVATE LIMITED	Director	30/09/2010	01/01/2010	-	Active	NO

Name :

Mr. Hemant Bhogilal Mehta

Designation :

Director

Address :

255/11, Prity, R.N.N, Road, Gathkopar (East), Mumbai 400077, Maharashtra, India

Date of Birth/Age :

31.05.1979

Date of Appointment :

30.09.2010

DIN No :

00580653

Other Directorship

S.No.	CIN/LLPIN	Name of the Company/ LLP	Current designation of the Director/ Designated Partner	Date of appointment at current designation	Original date of appointment	Date of cessation	Company/ LLP Status	Defaulting status
1	U24230MH1999PLC122956	AQUATIC FORMULATIONS (INDIA) LIMITED	Whole-time director	1/4/2010	7/12/1999	-	Active	NO
2	U24210MH1996PTC097827	OCEANIC TECHNO CHEM PRIVATE LIMITED	Director	19/03/2001	19/03/2001	-	Active	NO
3	U24230MH1996PTC097828	AQUATIC REMEDIES PRIVATE LIMITED	Director	30/09/2010	1/1/2010	-	Active	NO

Name :

Mr. Bhogilal Maneklal Mehta

Designation :

Director

Address :

255/11, Prity, R.N.N, Road, Gathkopar (East), Mumbai 400077, Maharashtra, India

Date of Birth/Age :

27.06.1945

Date of Appointment :

30.09.2010

DIN No :

00580668

Other Directorship

S.No.	CIN/LLPIN	Name of the Company/ LLP	Current designation of the Director/ Designated Partner	Date of appointment at current designation	Original date of appointment	Date of cessation	Company/ LLP Status	Defaulting status
1	U24230MH1999PLC122956	AQUATIC FORMULATIONS (INDIA) LIMITED	Director	7/12/1999	7/12/1999	-	Active	NO
2	U24210MH1996PTC097827	OCEANIC TECHNO CHEM PRIVATE LIMITED	Director	30/09/2010	1/1/2010	-	Active	NO
3	U24230MH1996PTC097828	AQUATIC REMEDIES PRIVATE LIMITED	Director	30/09/2010	1/1/2010	-	Active	NO

Name :

Mr. Nyalchand Maneklal Mehta

Designation :

Director

Address :

255/11, Prity, R.N.N, Road, Gathkopar (East), Mumbai 400077, Maharashtra, India

Date of Birth/Age :

23.03.1936

Date of Appointment :

30.09.2010

DIN No :

02728277

Other Directorship

S.No.	CIN/LLPIN	Name of the Company/ LLP	Current designation of the Director/ Designated Partner	Date of appointment at current designation	Original date of appointment	Date of cessation	Company/ LLP Status	Defaulting status
1	U24230MH1999PLC122956	AQUATIC FORMULATIONS (INDIA) LIMITED	Director	7/12/1999	7/12/1999	-	Active	NO
2	U24210MH1996PTC097827	OCEANIC TECHNO CHEM PRIVATE LIMITED	Director	30/09/2010	1/1/2010	-	Active	NO
3	U24230MH1996PTC097828	AQUATIC REMEDIES PRIVATE LIMITED	Director	30/09/2010	1/1/2010	-	Active	NO

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

AS ON 30.09.2010

Names of Shareholders	No. of Shares
Bharat Mehta	278735
Hitendra Nyalchand Mehta	226,370
Kirti Bhogilal Mehta	371870
Darshan Bhogilal Mehta	429870
Daksha B. Mehta	145500
Priti H Mehta	128000
Bijal K Mehta	146460
Nyalchand M Mehta	379870
Bhogilal M Mehta	359825
Jayshree Mehta	132500
Chandrika B Mehta	143000
Purvi Mehta	115000
Aquatic Formulations Private Limited, India	2790000
Hemant Mehta	472500
Bijal Hemant Mehta	100000
Bharat Mehta (HUF)	299500
Kirti Mehta (HUF)	351500
Nyalchand M Mehta (HUF)	349500
Bhogilal M Mehta (HUF)	350000
Hitendra Mehta (HUF)	315000
Darshan Mehta (HUF)	105000
Kishorekuar Bavishi	230000
R. N. Damania	240000
Mahesh Bavishi	200000
Anand Kamdar	190000
Monica Sharma	105000
Manoj Ajmera	145000
Saurabh Kamdar	250000
Nilesh Bavishi	120000
Ramila Ajmera	200000
Total	9670000

As on 30.09.2011

Equity Share Break up (Percentage of Total Equity)

Category	Percentage
Bodies corporate	28.85
Directors or relatives of Directors	53.78
Other top fifty shareholders	17.37
Total	100.00

BUSINESS DETAILS

Line of Business :

Trader, Exporter and Importers of Pharmaceutical Raw Materials and Bulk Active Ingredients.

Products :

Item Code No.(ITC Code)	Products Description
2900	Pharmaceutical Drugs

· Antiasthmatic

· Antibiotics / Antibacterial

· Anti Cancer

· Anticonvulsant

· Anti-diabetic

· Antidepressant

· Antifungal

· Antihistamine

· Antihypertensive

· Anti-inflammatory / Analgesic

· Antimalarials

· Antiprotozoal

· Antiretroviral

· Anti-Tuberculosis

· Antiulcerants

· Antiviral

· Hormones

· Macrolides

· Steroids

· Vitamins

Exports :

Products :

Pharmaceutical Raw Materials

Countries :

· African Countries

· Middle East

· Latin America

· South East Asia

Imports :

Products :

Pharmaceutical Raw Materials

Countries :

· China

· Korea

Terms :

Selling :

Credit (Depend on Parity)

Purchasing :

Credit (Depend on Parity)

GENERAL INFORMATION

Suppliers :

J.B. Khokhani and Company

Customers :

End Users

· Mecw Pharmaceutical Indore

No. of Employees :

55 (Approximately)

Bankers :

· ING Vysya Bank Limited, Unit No.2/3/4, Marathon Max Building, Opposite Nirmal Lifestyle, Mulund Goregaon Link Road (West), Mumbai-400080, Maharashtra, India

· Bank of Maharashtra, Lokmangal 1501, Shivajinagar, Pune – 411 005, Maharashtra, India

· HDFC Bank Limited, Mumbai, Maharashtra, India

· Bank of Maharashtra

Facilities :

CC / LC Rs.300.000 Millions (From ING Vysya Bank Limited)

(Rs. In Millions)

Secured Loan	As on 31.03.2011	As on 31.03.2010
Working capital loans banks secured	130.580	211.271
Loans taken for vehicles secured	1.638	0.000
Total	132.218	211.271
Unsecured Loan	As on 31.03.2011	As on 31.03.2010
Loans directors unsecured	7.179	9.135
Other debt unsecured	0.400	0.400
Total	7.579	9.535

Banking Relations :
Auditors :
Name :	C. B. Chhajed and Company Chartered Accountants
Address :	DGP House, Ground Floor, 88-C, Old Prabhadevi Road, Mumbai-400025, Maharashtra, India
PAN.:	AAAFC3565E
Enterprises over which Key Management Personnel and their relatives exercise significant influence or control :	· Oceanic Techno Chem Private Limited Address: 218/219, Kailash Plaza, Vallabh Baug Lane, Ghatkopar (East), Mumbai – 400 075, Maharashtra, India Line of Business: Exporter of Formulation · Aquatic Formulations ( India ) Private Limited Address: 218/219, Kailash Plaza, Vallabh Baug Lane, Ghatkopar (East), Mumbai – 400 075, Maharashtra, India Line of Business: Exporter of Formulation · Oceanic Media – Treat Private Limited

CAPITAL STRUCTURE

As on 31.03.2011

Authorised Capital :

No. of Shares	Type	Value	Amount
11000000	Equity Shares	Rs.10/- each	Rs.110.000 Millions

Issued, Subscribed & Paid-up Capital :

No. of Shares	Type	Value	Amount
9670000	Equity Shares	Rs.10/- each	Rs.96.700 Millions

FINANCIAL DATA

[all figures are in Rupees Millions]

ABRIDGED BALANCE SHEET

SOURCES OF FUNDS		31.03.2011	31.03.2010	31.03.2009
SHAREHOLDERS FUNDS
1] Share Capital		96.700	96.700	79.900
2] Share Application Money		0.000	0.000	0.000
3] Reserves & Surplus		68.897	48.924	36.220
4] (Accumulated Losses)		0.000	0.000	0.000
NETWORTH		165.597	145.624	116.120
LOAN FUNDS
1] Secured Loans		132.218	211.271	98.960
2] Unsecured Loans		7.579	9.535	6.162
TOTAL BORROWING		139.797	220.806	105.122
DEFERRED TAX LIABILITIES		0.000	0.000	0.000
TOTAL		305.394	366.430	221.242
APPLICATION OF FUNDS
FIXED ASSETS [Net Block]		6.638	4.374	4.032
Capital work-in-progress		0.000	0.000	0.000
INVESTMENT		21.611	21.518	36.717
DEFERREX TAX ASSETS		0.000	0.000	0.000
CURRENT ASSETS, LOANS & ADVANCES
	Inventories	95.672	110.901	52.431
	Sundry Debtors	678.067	600.290	422.942
	Cash & Bank Balances	47.683	34.235	3.727
	Other Current Assets	1.355	0.000	0.000
	Loans & Advances	49.401	39.609	22.436
Total Current Assets		872.178	785.035	501.536
Less : CURRENT LIABILITIES & PROVISIONS
	Sundry Creditors	516.426	418.916	269.537
	Other Current Liabilities	49.027	6.101	39.526
	Provisions	29.580	19.480	11.980
Total Current Liabilities		595.033	444.497	321.043
Net Current Assets		277.145	340.538	180.493
MISCELLANEOUS EXPENSES		0.000	0.000	0.000
TOTAL		305.394	366.430	221.242

PROFIT & LOSS ACCOUNT

	PARTICULARS		31.03.2011	31.03.2010	31.03.2009
	SALES
		Income	NA	1789.181	1496.074
		Other Income
		TOTAL	NA	1789.181	1496.074
Less	EXPENSES
		Office Expenses
		Administrative Expenses	NA	1782.486	1475.635
		Advertising Expenses
		TOTAL	NA	1782.486	1475.635
	PROFIT BEFORE TAX		30.073	20.204	20.439
Less	TAX		NA	7.500	7.105
	PROFIT AFTER TAX		NA	12.704	13.334
	TOTAL IMPORTS		570.967	380.963	47.714
	Earnings Per Share (Rs.)		NA	1.31	1.67

Particulars	31.03.2012
Sales Turnover (Approximately)	3150.000

Expected Sales (2012-13) : Rs.3500.000 Millions

The above information has been parted by Mr. Bharat Nyalchand Mehta

KEY RATIOS

PARTICULARS		31.03.2011	31.03.2010	31.03.2009
PAT / Total Income	(%)	NA	0.71	0.89
Return on Total Assets (PBT/Total Assets}	(%)	3.42	2.56	4.04
Return on Investment (ROI) (PBT/Networth)		0.18	0.14	0.18
Debt Equity Ratio (Total Liability/Networth)		4.44	4.57	3.67
Current Ratio (Current Asset/Current Liability)		1.47	1.77	1.56

LOCAL AGENCY FURTHER INFORMATION

Sr. No.	Check List by Info Agents	Available in Report (Yes / No)
1]	Year of Establishment	(Yes)
2]	Locality of the firm	(Yes)
3]	Constitutions of the firm	(Yes)
4]	Premises details	(Yes)
5]	Type of Business	(Yes)
6]	Line of Business	(Yes)
7]	Promoter's background	(Yes)
8]	No. of employees	(Yes)
9]	Name of person contacted	(Yes)
10]	Designation of contact person	(Yes)
11]	Turnover of firm for last two years	(Yes)
12]	Profitability for last three years	(Yes)
13]	Reasons for variation <> 20%	----------------------
14]	Estimation for coming financial year	(Yes)
15]	Capital in the business	(Yes)
16]	Details of sister concerns	(Yes)
17]	Major suppliers	(Yes)
18]	Major customers	(Yes)
19]	Payments terms	(Yes)
20]	Export / Import details (if applicable)	(Yes)
21]	Market information	----------------------
22]	Litigations that the firm / promoter involved in	----------------------
23]	Banking Details	(Yes)
24]	Banking facility details	(Yes)
25]	Conduct of the banking account	----------------------
26]	Buyer visit details	----------------------
27]	Financials, if provided	(Yes)
28]	Incorporation details, if applicable	(Yes)
29]	Last accounts filed at ROC	(Yes)
30]	Major Shareholders, if available	(Yes)
31]	Date of Birth of Proprietor/Partner/Director, if available	(Yes)
32]	PAN of Proprietor/Partner/Director, if available	(No)
33]	Voter ID No of Proprietor/Partner/Director, if available	(No)
34]	External Agency Rating, if available	(No)

OPERATING AND FINANCIAL RESULTS: -

The Financial result of the company shows a net profit before tax of sum of Rs.30.073 Millions which the directors propose to retain for business purposes.

TRADE REFERENCES

· J.B. Khokhani and Company

· Mecw Pharmaceutical Indore

BANKERS CHARGES REPORT AS PER REGISTRY

Corporate identity number of the company	U24230MH1996PTC097828
Name of the company	AQUATIC REMEDIES PRIVATE LIMITED
Address of the registered office or of the principal place of business in India of the company	218/219, Kailash Plaza, Vallabh Baug Lane, Ghatkopar (East), Mumbai – 400 075, Maharashtra, India forum.fga@gmail.com
This form is for	Modification of charge
Charge identification (ID) number of the charge to be modified	10194635
Type of charge	Immovable property
Particular of charge holder	ING Vysya Bank Limited, Unit No.2/3/4, Marathon Max Building, Opposite Nirmal Lifestyle, Mulund Goregaon Link Road (West), Mumbai-400080, Maharashtra, India vlaxman@vnsl.com
Nature of instrument creating charge	Memorandum Recording Transaction of Creation of Equitqble Mortgage by Deposit of Title Deeds by Constructive Delivery (for Additional loan /advances against the same property /ies- For self or Third Party Loan).
Date of instrument Creating the charge	13.04.2012
Amount secured by the charge	Rs.310.000 Millions
Brief of the principal terms an conditions and extent and operation of the charge	Rate of Interest OD-SIT/BD : IVBR + 2.05%. Terms of Repayment Loan/s shall be Repayable on demand. Margin OD-SIT/BD: 25% against Raw Materials, Work in process, Finished goods, Packing material, Book debts. WCDL (Sublimit of OD-SIT/BD): 25% against Stock and Book Debts. ILC/FLC: 10%. BC (Sublimit of LC): 10%. Extent and Operation of the charge The Company created an equitable mortgage by way of deposit of title deeds (by constructive delivery) in respect of its immovable properties as stated under item No.15 below as security for the due repayment of dues under the credit facilities aggregating Rs.310.000 Millions by the Company, including principal amount of the Facility, interest, liquidated damages, costs, charges and expenses etc. Others OD-SIT/BD : Rs.120.000 Millions WCDL (Sublimit of OD-SIT/BD) : Rs.(90.000) Millions ILC/FLC : Rs.190.000 Millions BC (Sublimit of LC) : Rs.(140.000) Millions.
Short particulars of the property or asset(s) charged (including complete address and location of the property)	Immovable Property being office No.18, 2nd Floor in the building called Kailash Plaza, situated at the land bearing final Plot No.355 situated at village Vallabh Lane, Ghatkopar (E), Mumbai-400 077. Immovable Property being office No.19, 2nd Floor in the building called Kailash Plaza, situated at the land bearing final Plot No.355 situated at village Vallabh Lane, Ghatkopar (E), Mumbai-400 077.
Date of instrument modifying the charge	12.04.2012
Particulars of the present modification	The charge shall now stands increased from Rs.290.000 Millions to Rs.310.000 Millions in favour of the Bank against the equitable mortgage of immovable properties being office No.18 and 19 in Kailash Plaza, Vallabh Lane, Ghatkopar (E), Mumbai-400 077.

FIXED ASSETS

· Air conditioner

· Cellular Phone

· Cine System

· Computer

· Coffee Machine

· Cycle

· EPABX System

· Fan

· Fridge

· Motor Car

· Office Equipment

· Printer / Fax

· Scooter

· Television

· Washing Machine

· Xerox Machine

AS PER WEBSITE

PROFILE

Subject Remedies story dates 2 decades back, as a small Pharmaceutical Formulations company started by Mr. Bharat Mehta that is now grown into a large and dynamic business house, which currently occupies a leading position in the fields of Bulk Drugs Pharmaceutical Formulations in the Domestic as well as Export Market. These 2 decades of experience since 1985, have taken Aquatic Remedies from strength to strength in the health care business to a next level.

They started their venture initially with domestic trading in bulk drugs and gradually ventured into the areas of export, imports, and indenting. Their innovation about Constant diversification and expansion has resulted in creation of large clientele in domestic and international markets. Furthermore, it is a contributing factor for the high turnover rate, which increased by 400% in the last decade. Thus, The Company strides to achieve global standards in the field of Pharmaceuticals and bulk drugs.

CMT REPORT (Corruption, Money Laundering & Terrorism]

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

1] INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

2] Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

3] Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

4] Record on Financial Crime :

Charges or conviction registered against subject: None

5] Records on Violation of Anti-Corruption Laws :

Charges or investigation registered against subject: None

6] Records on Int’l Anti-Money Laundering Laws/Standards :

Charges or investigation registered against subject: None

7] Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

8] Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

9] Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

10] Press Report :

No press reports / filings exists on the subject.

CORPORATE GOVERNANCE

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

CONTRAVENTION

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

FOREIGN EXCHANGE RATES

Currency	Unit	Indian Rupees
US Dollar	1	Rs.55.70
UK Pound	1	Rs.87.55
Euro	1	Rs.68.85

INFORMATION DETAILS

Information Gathered by :	SVA
Report Prepared by :	NTH

SCORE & RATING EXPLANATIONS

SCORE FACTORS	RANGE	POINTS
HISTORY	1~10	4
PAID-UP CAPITAL	1~10	4
OPERATING SCALE	1~10	5
FINANCIAL CONDITION
--BUSINESS SCALE	1~10	5
--PROFITABILIRY	1~10	3
--LIQUIDITY	1~10	3
--LEVERAGE	1~10	3
--RESERVES	1~10	3
--CREDIT LINES	1~10	3
--MARGINS	-5~5	--
DEMERIT POINTS
--BANK CHARGES	YES/NO	YES
--LITIGATION	YES/NO	NO
--OTHER ADVERSE INFORMATION	YES/NO	NO
MERIT POINTS
--SOLE DISTRIBUTORSHIP	YES/NO	NO
--EXPORT ACTIVITIES	YES/NO	YES
--AFFILIATION	YES/NO	YES
--LISTED	YES/NO	NO
--OTHER MERIT FACTORS	YES/NO	YES
TOTAL		33

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

Financial condition (40%) Ownership background (20%) Payment record (10%)

Credit history (10%) Market trend (10%) Operational size (10%)

RATING EXPLANATIONS

RATING		STATUS	PROPOSED CREDIT LINE
>86	Aaa	Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums	Unlimited
71-85	Aa	Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums	Large
56-70	A	Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums	Fairly Large
41-55	Ba	Overall operation is considered normal. Capable to meet normal commitments.	Satisfactory
26-40	B	Capability to overcome financial difficulties seems comparatively below average.	Small
11-25	Ca	Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity	Limited with full security
<10	C	Absolute credit risk exists. Caution needed to be exercised	Credit not recommended
-	NB	New Business	-

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.